• 1.

    Baber U, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5:S53S61.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Fang Y, et al. Early chronic kidney disease–mineral bone disorder stimulates vascular calcification. Kidney Int 2014; 85:142150.

  • 3.

    Li X, Giachelli CM. Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens 2007; 16:325328.

  • 4.

    Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75:890897.

  • 5.

    Schafer C, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112:357366.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Suliman ME, et al. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Adv Clin Chem 2008; 46:217262.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Cranenburg EC, et al. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009; 101:359366.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Schurgers LJ, et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010; 5:568575.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Schlieper G, et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESKD. J Am Soc Nephrol 2011; 22:387395.

  • 10.

    Fusaro M, et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012; 27:22712278.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Delanaye P, et al. Dephosphorylated-uncarboxylated matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014; 15:145.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Meuwese CL, et al. Associations between thyroid hormones, calcification inhibitor levels and vascular calcification in end-stage renal disease. PLoS One 2015; 10:e0132353.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Thamratnopkoon S, et al. Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 2017; 135:167172.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Westenfeld R, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012; 59:186195.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Caluwe R, et al. Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol Dial Transplant 2014; 29:13851390.

Vitamin K and Vascular Calcification

  • 1 Pascale Khairallah, MD, is a nephrology fellow at Columbia University Medical Center.
Restricted access
Save